LLMpediaThe first transparent, open encyclopedia generated by LLMs

Journal of Hepatology

Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Organovo Hop 6 terminal

This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.

Journal of Hepatology
TitleJournal of Hepatology
DisciplineHepatology
AbbreviationJ. Hepatol.
PublisherElsevier on behalf of the European Association for the Study of the Liver
FrequencyMonthly
History1985–present
Impact30.083
Impact-year2023
Issn0168-8278

Journal of Hepatology is a peer-reviewed medical journal covering clinical and translational research in liver disease. It publishes original research, reviews, guidelines, and correspondence addressing viral hepatitis, cirrhosis, liver transplantation, and hepatocellular carcinoma. The journal is associated with major professional societies and features contributions from researchers affiliated with institutions across Europe, North America, and Asia.

History

The journal was established in 1985 amid a period of expanding specialization in medicine that included the founding of societies such as the European Association for the Study of the Liver, the American Association for the Study of Liver Diseases, and the growth of centers such as the Mayo Clinic and Johns Hopkins Hospital. Early editorial leadership drew on figures linked to institutions like Addenbrooke's Hospital, Charité – Universitätsmedizin Berlin, and Karolinska Institutet. Over decades the journal paralleled developments exemplified by events like the discovery of hepatitis B virus markers and the advent of antiviral regimens following milestones at Institut Pasteur and Centers for Disease Control and Prevention. Shifts in publishing mirrored transitions at companies such as Elsevier and collaborations with organizations comparable to European Commission-funded networks. Landmark eras of the journal correspond with advances by investigators from Stanford University, Massachusetts General Hospital, University of Tokyo, and King's College London.

Scope and focus

The journal emphasizes translational and clinical hepatology, encompassing topics from virology exemplified by work linked to Robert Gallo-era retrovirology centers to immunopathology research associated with National Institutes of Health programs. It addresses liver transplantation studies related to centers like Cleveland Clinic and surgical advances traced to teams at Hospital Clínic de Barcelona. Research in oncology connects to institutions such as Memorial Sloan Kettering Cancer Center and Institut Gustave Roussy for hepatocellular carcinoma. Public health–oriented articles intersect with initiatives at World Health Organization and regional programs resembling European Centre for Disease Prevention and Control. The journal also publishes guideline statements developed in partnership with societies akin to British Society of Gastroenterology and specialist networks including Asian Pacific Association for the Study of the Liver.

Editorial board and publishers

The editorial governance comprises an editor-in-chief supported by associate editors and an international editorial board drawn from universities and hospitals such as Imperial College London, University of California, San Francisco, University of Oxford, Seoul National University Hospital, and Hopital Beaujon. Publishing operations are handled by Elsevier on behalf of the European Association for the Study of the Liver with production workflows influenced by standards used by publishers like Wiley-Blackwell and Springer Nature. The journal's peer-review procedures reflect models employed at journals including The Lancet, New England Journal of Medicine, and specialty journals affiliated with professional bodies such as Royal College of Physicians.

Abstracting and indexing

The journal is indexed in major bibliographic databases comparable to PubMed, Scopus, Web of Science, and specialized repositories akin to EMBASE. Abstracting services that list the journal parallel those used by high-impact titles such as Nature and Science. Inclusion in citation indices ties the journal's metrics to tools maintained by organizations like Clarivate, which publishes the Journal Citation Reports.

Impact and reception

With an impact factor reported in the high tens, the journal is regarded among leading specialty publications alongside titles such as Hepatology (journal), Gastroenterology (journal), and The BMJ. It has been cited in consensus documents and guidelines issued by entities like World Health Organization and referenced in policy discussions involving agencies similar to European Medicines Agency and Food and Drug Administration. Reviews in medical press and coverage in outlets such as Nature Medicine and The Lancet Gastroenterology & Hepatology have highlighted its role in shaping clinical practice and research priorities.

Notable publications and contributions

The journal has published influential randomized trials, guideline papers, and mechanistic studies that informed antiviral therapy development and liver transplant management. Key contributions include work on direct-acting antivirals building on molecular virology traditions from laboratories linked to University of California, San Diego and clinical trial networks associated with National Institute for Health and Care Research. The journal disseminated consensus guidelines similar in impact to those from European Association for the Study of the Liver leadership and multicenter cohort analyses involving centers such as Mount Sinai Health System, Hôpital Paul Brousse, and Royal Free Hospital. It has also featured basic science collaborations tied to research groups at Cold Spring Harbor Laboratory, Max Planck Society, and Institute of Cancer Research.

Access and publication model

The journal operates a hybrid model combining subscription access managed by Elsevier with open access options in line with policies promoted by funders such as Wellcome Trust, Horizon 2020, and Bill & Melinda Gates Foundation. Authors may select gold open access routes consistent with mandates from organizations like cOAlition S and deposition practices at repositories analogous to Europe PMC. Publication fees and licensing choices reflect industry standards used by major publishers including Taylor & Francis and SAGE Publications.

Category:Medical journals Category:Hepatology